Previous studies have investigated IL-8 and MCP-1 only in certain patient groups such as HIV-infected patients, autoimmune patients (with psoriasis, rheumatoid arthritis, or type 1 diabetes mellitus), or in patients with immune-mediated conditions. This evidence concerns the gene CXCL8 and diabetes mellitus.